Daniel Rupp
Impact in
- Virology top 2%
- HIV Research and Treatment
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- Hepatitis C virus research 7
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Ralf F. W. Bartenschlager (9 shared papers)Oliver T. Keppler (3 shared papers)Oliver Till Fackler (2 shared papers)Stefanie Homann (2 shared papers)Nadine Tibroni (2 shared papers)Christine Goffinet (2 shared papers)Anja Habermann (1 shared paper)Sonja Welsch (1 shared paper)
- Journals
- PLoS Pathogens (2 papers)PLoS ONE (2 papers)Seminars in Liver Disease (1 paper)Antiviral Research (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)
- Partner nations
- GermanyNetherlandsUnited Kingdom
In The Last Decade
Daniel Rupp
14 papers receiving 736 citations
Peers
Comparison fields: 5 of 59
- Virology 276
- Hepatology 263
- Infectious Diseases 181
- Epidemiology 295
- Immunology 142
Countries citing papers authored by Daniel Rupp
This map shows the geographic impact of Daniel Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rupp more than expected).
Fields of papers citing papers by Daniel Rupp
This network shows the impact of papers produced by Daniel Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rupp. The network helps show where Daniel Rupp may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 229 | |
| 2 | 2013 | 173 | |
| 3 | 2016 | 101 | |
| 4 | 2010 | 63 | |
| 5 | 2015 | 54 | |
| 6 | 2014 | 39 | |
| 7 | 2015 | 34 | |
| 8 | 2017 | 17 | |
| 9 | 2016 | 11 | |
| 10 | 2014 | 10 | |
| 11 | 2010 | 5 | |
| 12 | 2016 | 4 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 2 |
About Daniel Rupp
Daniel Rupp is a scholar working on Hepatology, Infectious Diseases, Virology, Epidemiology and Immunology, having authored 14 papers that have together received 746 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (6 papers), Hepatitis B Virus Studies (4 papers), HIV Research and Treatment (3 papers), RNA Interference and Gene Delivery (3 papers), Biochemical and Molecular Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Virology (276 citations), Hepatology (263 citations), Infectious Diseases (181 citations), Epidemiology (295 citations) and Immunology (142 citations). Daniel Rupp has collaborated with scholars based in Germany, Netherlands and United Kingdom. Frequent co-authors include Ralf F. W. Bartenschlager, Oliver T. Keppler, Oliver Till Fackler, Stefanie Homann, Nadine Tibroni, Christine Goffinet, Anja Habermann, Sonja Welsch, Ina Allespach and Jacomine Krijnse‐Locker. Their work appears in journals such as PLoS Pathogens, PLoS ONE, Seminars in Liver Disease, Antiviral Research and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.